Chia Tai Tianqing Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHIA TAI TIANQING
CHIA TAI TIANQING has three approved drugs.
There are two tentative approvals on CHIA TAI TIANQING drugs.
Summary for Chia Tai Tianqing
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Chia Tai Tianqing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chia Tai Tianqing | ERIBULIN MESYLATE | eribulin mesylate | SOLUTION;INTRAVENOUS | 218743-001 | Mar 4, 2025 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chia Tai Tianqing | FULVESTRANT | fulvestrant | SOLUTION;INTRAMUSCULAR | 211422-001 | Feb 7, 2020 | AO | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chia Tai Tianqing | FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 212143-001 | Mar 3, 2021 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
